Native Renal Arteries Denervation as a Therapy of Refractory Hypertension in Patient after Heart and Kidney Transplantation-5 Years of Observation.
heart transplantation
innovative treatment
kidney transplantation
refractory hypertension
renal arteries denervation
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
23 Aug 2023
23 Aug 2023
Historique:
received:
02
06
2023
revised:
08
08
2023
accepted:
19
08
2023
medline:
9
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
epublish
Résumé
This case report describes a 59-year-old male patient after heart and kidney transplantation, subsequently diagnosed with refractory hypertension since implemented antihypertensive pharmacotherapy consisting of six agents did not provide a substantial therapeutic response. Elevated blood pressure and its impact on a hypertrophied transplanted heart and impaired renal graft function have led to a significant deterioration in the patient's cardiovascular risk profile. To address this issue, a native renal arteries denervation was performed. It resulted in a noteworthy decrease in both systolic and diastolic pressure values, thus manifesting a positive hypotensive effect. Furthermore, a sustainable reduction of left ventricular mass and stabilization in kidney graft function were noticed. The presented case provides evidence that renal denervation can be an efficacious complementary treatment method in individuals who received kidney and heart grafts as it leads to a decrease in cardiovascular risk.
Identifiants
pubmed: 37685525
pii: jcm12175458
doi: 10.3390/jcm12175458
pmc: PMC10487959
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
J Am Coll Cardiol. 2022 Nov 15;80(20):1881-1883
pubmed: 36357088
BMC Cardiovasc Disord. 2021 Aug 10;21(1):388
pubmed: 34376149
Int J Mol Sci. 2023 Apr 15;24(8):
pubmed: 37108465
Hipertens Riesgo Vasc. 2023 May 17;:
pubmed: 37208278
JACC Case Rep. 2022 Nov 03;4(23):101669
pubmed: 36507297
Lancet. 2002 Dec 14;360(9349):1903-13
pubmed: 12493255
Transplant Proc. 2018 Dec;50(10):3946-3949
pubmed: 30577292
JACC Heart Fail. 2021 Apr;9(4):301-313
pubmed: 33795116
Sci Rep. 2023 May 29;13(1):8664
pubmed: 37248400
J Pediatr Pharmacol Ther. 2022;27(5):428-435
pubmed: 35845561
Transplant Proc. 2016 Jun;48(5):1858-60
pubmed: 27496508
JAMA. 2020 Jan 21;323(3):248-255
pubmed: 31961420
Am J Kidney Dis. 2022 Oct;80(4):527-535
pubmed: 35598810
N Engl J Med. 2014 Apr 10;370(15):1393-401
pubmed: 24678939
Am J Transplant. 2005 Nov;5(11):2725-31
pubmed: 16212633
J Korean Med Sci. 2013 Jun;28(6):951-4
pubmed: 23772164
Circ Res. 2019 Mar 29;124(7):1061-1070
pubmed: 30920924
Nephrol Dial Transplant. 2022 Mar 25;37(4):638-644
pubmed: 33200209
Lancet. 2022 Oct 22;400(10361):1405-1416
pubmed: 36130612
Ann Transplant. 2012 Jan-Mar;17(1):50-7
pubmed: 22466909
Hypertens Res. 2023 Jan;46(1):280-288
pubmed: 36241705
Eur Heart J. 2018 May 21;39(20):1799-1806
pubmed: 28087606